Phase 2 Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (Pts) With Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): An Updated Safety Analysis
Phase 2 Multicenter Study of Pomalidomide (POM) Plus Low-Dose Dexamethasone (LoDEX) in Patients (Pts) With Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI): An Updated Safety Analysis
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2017
Συγγραφείς:
Weisel, Katja Dimopoulos, Meletios Athanasios Van de Donk, Niels Ramasamy, Karthik Gamberi, Barbara Streetly, Matthew Offidani, Massimo Bridoux, Frank de la Rubia, Javier Kueenburg, Elisabeth others
